We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
151
Illinois Tool Works
ITW
$84.5B
$540K 0.23%
+2,184
New +$528K
EQT icon
152
EQT Corp
EQT
$32.3B
$540K 0.23%
9,254
+1,200
+15% +$64.8K
ANSS
153
DELISTED
Ansys
ANSS
$539K 0.23%
1,536
-612
-28% -$200K
CPNG icon
154
Coupang
CPNG
$29.2B
$533K 0.23%
17,777
+1,616
+10% +$41.4K
CRUS icon
155
Cirrus Logic
CRUS
$6.26B
$530K 0.23%
+5,082
New +$498K
EPAM icon
156
EPAM Systems
EPAM
$5.03B
$526K 0.23%
2,977
+1,782
+149% +$298K
UAA icon
157
Under Armour
UAA
$2.6B
$526K 0.23%
77,009
+20,412
+36% +$127K
EXC icon
158
Exelon
EXC
$47B
$524K 0.23%
12,070
-5,801
-32% -$258K
TSLA icon
159
Tesla
TSLA
$1.3T
$517K 0.22%
+1,629
New +$491K
AES icon
160
AES
AES
$10.5B
$515K 0.22%
48,955
+119
+0.2% +$1.27K
TFC icon
161
Truist Financial
TFC
$64B
$515K 0.22%
+11,979
New +$469K
VZ icon
162
Verizon
VZ
$196B
$515K 0.22%
+11,891
New +$515K
TPR icon
163
Tapestry
TPR
$32.8B
$514K 0.22%
+5,856
New +$443K
HLI icon
164
Houlihan Lokey
HLI
$9.02B
$513K 0.22%
+2,852
New +$479K
ELF icon
165
e.l.f. Beauty
ELF
$5.81B
$511K 0.22%
4,107
-5,809
-59% -$496K
COR icon
166
Cencora
COR
$61.2B
$511K 0.22%
+1,704
New +$491K
ALLE icon
167
Allegion
ALLE
$14.4B
$509K 0.22%
+3,533
New +$483K
EME icon
168
Emcor
EME
$36B
$507K 0.22%
948
-964
-50% -$425K
LTH icon
169
Life Time Group Holdings
LTH
$9.79B
$507K 0.22%
+16,711
New +$496K
HEI icon
170
HEICO Corp
HEI
$51.4B
$505K 0.22%
1,539
+426
+38% +$118K
HRB icon
171
H&R Block
HRB
$5.86B
$500K 0.22%
+9,113
New +$526K
COF icon
172
Capital One
COF
$134B
$500K 0.22%
+2,349
New +$438K
KO icon
173
Coca-Cola
KO
$375B
$499K 0.22%
7,052
-3,823
-35% -$272K
BX icon
174
Blackstone
BX
$110B
$499K 0.22%
3,333
-61
-2% -$8.38K
VEEV icon
175
Veeva Systems
VEEV
$37.4B
$498K 0.22%
+1,728
New +$429K
5 6
7
8 9

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.